ARCHIVES

NSABP “Saddened” But Some Patient Advocates Hail “Courageous” Decision.

This article is from The Cancer Letter archive.

Vol. 33 No. 24 | June 22, 2007

Download PDF Visit The Full Archive

Related Articles

BMS Demands Resignation Of Two ImClone Executives

February 8, 2002

Greenwald Lists Plans For $40 Million Raise In Prevention & Control

December 3, 1993

Zubrod To Retire as Miami Director; Baker Succeeds Brennan As Director Of Detroit Center

January 29, 1988

FASEB Calls For 15% Increase For NIH Next Fiscal Year.

January 26, 2001

Oral UFT Equivalent To FULV In Stage II and III Colon Cancer

July 30, 2004

FDA Oncologic Drugs Advisory Committee: Trials In A Small Indication Tell Big Story About Pitfalls of Delaying Progression

April 15, 2011